腺苷酸激酶抗体uantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
widespread effects on the cardiovascular, nervous, respiratory, and immune systems and inhibitors of ADK could play an important pharmacological role in increasing intravascular adenosine 腺苷酸激酶抗体concentrations and acting as antiinflammatory agents. The encoded protein does not present any sequence similarities to other well characterized mammalian nucleoside kinases. In contrast, 2 regions were identified with significant sequence identity to microbial ribokinase and fructokinases and a bacterial inosine/guanosine kinase. Thus, ADK is a structurally distinct mammalian nucleoside kinase that appears to be akin to sugar kinases of microbial origin. Animal studies have demonstrated that a deficiency 腺苷酸激酶抗体of adenosine metabolism a powerful contributor to the development of neonatal hepatic steatosis, providing a model for the rapid development of postnatally lethal fatty liver.
腺苷酸激酶抗体Also known as:
Adenosine kinase; AK; 5033405D03Rik; AI255373; AI987814; MGC6593; 2310026J05Rik; Adenosine 5'-phosphotransferase; OTTHUMP00000019864; OTTHUMP00000019865; ADK_HUMAN; Adenosine kinase; AK; Full=Adenosine 5'-phosphotransferase.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, .
●
Immunogen: KLH conjugated synthetic peptide derived from human ADK/adenylate kinase.
●
Predicted Molecular Weight: 41kDa.
腺苷酸激酶抗体Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user
kl022Ra01血管内皮细胞蛋白C受体(PROCR)多克隆抗体Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl024Bo01内分泌腺来源血管内皮生长因子(EG-VEGF)多克隆抗体Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Hu01内分泌腺来源血管内皮生长因子(EG-VEGF)多克隆抗体Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Mu01内分泌腺来源血管内皮生长因子(EG-VEGF)多克隆抗体Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Ra01内分泌腺来源血管内皮生长因子(EG-VEGF)多克隆抗体Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl025Bo01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Eq01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Gu01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Hu01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Mu01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Ra01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Si01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl026Hu01趋化因子C-C-基元配体3样蛋白1(CCL3L1)多克隆抗体Polyclonal Antibody to Chemokine C-C-Motif Ligand 3 Like Protein 1 (CCL3L1)
kl026Mu01趋化因子C-C-基元配体3样蛋白1(CCL3L1)多克隆抗体Polyclonal Antibody to Chemokine C-C-Motif Ligand 3 Like Protein 1 (CCL3L1)
kl027Hu01红细胞生成素受体(EPOR)多克隆抗体Polyclonal Antibody to Erythropoietin Receptor (EPOR)
kl027Ra01红细胞生成素受体(EPOR)多克隆抗体Polyclonal Antibody to Erythropoietin Receptor (EPOR)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话